The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar Lines
NCT05364580
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
269
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
BIOLOGICAL:
PROTOXIN
BIOLOGICAL:
Botox®
Sponsor
Protox Inc.